Treatment of B-cell malignancies in children with a modified BFM-NHL 90 protocol in Argentina

Med Pediatr Oncol. 2003 Nov;41(5):488-90. doi: 10.1002/mpo.10288.
No abstract available

MeSH terms

  • Adolescent
  • Antineoplastic Combined Chemotherapy Protocols / therapeutic use*
  • Argentina
  • Asparaginase / therapeutic use*
  • Child
  • Child, Preschool
  • Cohort Studies
  • Daunorubicin / therapeutic use*
  • Dose-Response Relationship, Drug
  • Drug Administration Schedule
  • Female
  • Humans
  • Lymphoma, B-Cell / diagnosis
  • Lymphoma, B-Cell / drug therapy*
  • Lymphoma, B-Cell / mortality
  • Male
  • Maximum Tolerated Dose
  • Prednisone / therapeutic use*
  • Prognosis
  • Retrospective Studies
  • Risk Assessment
  • Survival Rate
  • Treatment Outcome
  • Vincristine / therapeutic use*

Substances

  • Vincristine
  • Asparaginase
  • Prednisone
  • Daunorubicin

Supplementary concepts

  • PVDA protocol